RNS Number : 6295A
Vela Technologies PLC
31 May 2019

31 May 2019


Vela Technologies plc

("Vela Technologies" or the "Company")


Total Voting Rights


Vela Technologies (AIM: VELA), announces that the Company's issued share capital as at the date of this announcement comprises 1,452,958,416 ordinary shares of 0.1p each, with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury and therefore the total number of Ordinary Shares and voting rights in the Company is 1,452,958,416.

The above figure of 1,452,958,416 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact: 

Vela Technologies plc


Brent Fitzpatrick, Non-Executive Chairman

Antony Laiker, Director

Tel: +44 (0) 7802 262 443

Allenby Capital Limited

(Nominated Adviser)

Nick Athanas/Asha Chotai

Tel: +44 (0) 20 3328 5656

Smaller Company Capital Limited

(Joint Broker)

Rupert Williams/Jeremy Woodgate

Tel: +44 (0) 20 3651 2910

SVS Securities Limited

(Joint Broker)

Elliot Hance


Tel: +44 (0) 20 3700 0100

About Vela Technologies

Vela Technologies (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. There are currently 12 investments in the portfolio which either have developed ways of utilising technology or developing technology with a view to disrupting the businesses or sector in which they operate. More recently, Vela Technologies has also started to focus on existing listed companies where valuations may offer additional opportunities. 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.